Association of Mutation and Polymorphism in Lipoprotein Lipase Gene with Coronary Heart Disease in Some Iraqi Patient

Abduqader W. Rasheid

doi:10.47134/biology.v2i2.3738

Authors

Abduqader W. Rasheid The Open Educational College

DOI:

https://doi.org/10.47134/biology.v2i2.3738

Keywords:

Lipase Polymorphism, Coronary Heart Disease, Cholesterol, Triglyceride, RFLP

Abstract

Prior research has assessed the correlations between the likelihood of acquiring diabetes mellitus and the polymorphism in the cholesterol ester transfer protein (LIPASE GENE). Chronic hyperglycemia and abnormalities in the metabolism of carbohydrates, fats, and proteins due to deficiencies in insulin production, action, or both are characteristics of the metabolic condition known as diabetes mellitus (DM), which has several etiologies. However, the conclusions are still up for debate. This study sought to determine whether lipid profile abnormalities in Iraqi diabetic patients were associated with the LIPASE GENE. Methods, To shed light on the relationships between the LIPASE GENE TaqIB polymorphism, HDL-C levels, and diabetes mellitus, we performed a meta-analysis of the literature. Findings: This study included 160 Iraqi participants, 90 of whom had diabetes mellitus, and 70 of whom served as controls. Table 1 displays the population study's blood lipid data. TC, TG, LDL-C, and VLDL-C were all considerably greater (P<0.0001) in the patient group than in the control group, with the exception of HDL-C, which was lower (P<0.0001). In this study, there were more men (75.55%) than women (24.4%) with type 2 diabetes. The large percentage of men in this research may result from the demographics of the hospital's patients, who tend to seek medical care more frequently than women to have more free time because most of them are retired. Included in the correlation between HDL-C concentration and lipase polymorphism. The LIPASE GENE gene has been shown to have a variety of single nucleotide polymorphisms. The influence of the rs708272 (g.5454G>A) polymorphism on HDL-C focus has been explained. This study aimed to evaluate the LIPASE gene site polymorphism and its effect on blood lipids in Iraqi patients with lipid problems. Since a few evaluations listed the LIPASE GENE polymorphism's association with the HDL level we decided to use it because we couldn't locate any Iraqi studies that addressed this polymorphism.

References

Abu-Amero K.K., Wyngaard C.A., Al-Boudari O.M., Kambouris M., Dzimiri N. Lack of association of lipoprotein lipase gene polymorphisms with coronary artery disease in the Saudi Arab population. Arch. Pathol. Lab. Med. 2003;127:597–600

Al-Jafari A.A., Daoud M.S., Mobeirek A.F., Al Anazi M.S. DNA polymorphisms of the lipoprotein lipase gene and their association with coronary artery disease in the Saudi population. Int. J. Mol. Sci. 2012;13:7559–7574.

Abdel Hamid M.M., Ahmed S., Salah A., Tyrab E.M., Yahia L.M., Elbashir E.A. et al. (2015) Association of lipoprotein lipase gene with coronary heart disease in Sudanese population. J. Epidemiol. Glob. Health 5, 405–407.

Abd El-Aziz T.A., Mohamed R.H. and Hashem R.M. (2011) Association of lipoprotein lipase and apolipoprotein C-III genes polymorphism with acute myocardial infarction in diabetic patients. Mol. Cell. Biochem. 354, 141–150

Allan CM, Larsson M, Jung RS, Ploug M, Bensadoun A, Beigneux AP, et al. Mobility of "HSPG-bound" LPL explains how LPL is able to reach GPIHBP1 on capillaries. J lipid Res (2017) 58(1):216–25.

Ashok K. M., Veera Subhashini N.G., Kanthimathi S., SaiBabu R., Ramesh A., Cherian KM. et al. (2010) Associations for lipoprotein lipase and peroxisome proliferator-activated receptor-gamma gene and coronary artery disease in an Indian population. Arch. Med. Res. 41, 19–25 .

Amps L, Reina M, Llobera M, Vilaro S, Olivecrona T. Lipoprotein lipase: cellular origin and functional distribution. Am J Physiology-Cell Physiol (1990) 258(4 Pt 1):C673–81.

Ani, A., Ani M.Moshtaghie A.A. & Ahmad vand H. (2010) Effect of titanium on lipoprotein lipase activity in vivo and in vitro. J. Trace Elem. Med. Biol. 24, 95–98.

Auer, R. C., Khetarpal S.A., Hand N.J. and Rader D.J. (2016) Therapeutic targets of triglyceride metabolism as informed by human genetics. Trends Mol. Med. 22, 328–340.

Auwerx J, Leroy P, Schoonjans K. Lipoprotein lipase: recent contributions from molecular biology. Crit Rev Clin Lab Sci (1992) 29(3-4):243–68.

Aziz, T.A., Mohamed R.H. and El-Shal A.S. (2023) Synergistic effect between lipoprotein lipase and apolipoprotein C3 genes in determining the severity of coronary artery disease. J. Cardiovasc. Transl. Res. 6, 430–435

Bankaitis VA and Wang Y, Lipoprotein Lipase Sorting: Sphingomyelin and a Proteoglycan Show the Way. Trends in Cell Biology, 2020. b

Bahrami M., Barati H., Jahani M.M., Fatemi A., Sharifi Z., Eydi A. et al. (2015) Lipoprotein lipase gene variants: Association with acute myocardial infarction and lipid profiles. Egypt. J. Med. Hum. Genet. 16, 327–332

Beigneux AP, Allan CM, Sandoval NP, Cho GW, Heizer PJ, Jung RS, et al. Lipoprotein lipase is active as a monomer. Proc Natl Acad Sci (2019) 116(13):6319–28.

Bhattacharya, A, et al., Hepatic Sel1L-Hrd1 ER-associated degradation (ERAD) manages FGF21 levels and systemic metabolism via CREBH. The EMBO journal, 2018. 37(22): p. e99277.

Blanchette-Mackie EJ, Masuno H, Dwyer NK, Olivecrona T, Scow RO. Lipoprotein lipase in myocytes and capillary endothelium of heart: immunocytochemical study. Am J Physiology-Endocrinology Metab (1989) 256(6 Pt 1):E818–28.

Chen Q., Razzaghi H., Demirci F.Y., Kamboh M.I. Functional significance of lipoprotein lipase HindIII polymorphism associated with the risk of coronary artery disease. Atherosclerosis. 2008;200:102–108.

Clee, S. M., Bissadag N., Miao F., Miao L., Marais A.D., Henderson H.E. et al. (2000) Hayden plasma and vessel wall lipoprotein lipase have different roles in atherosclerosis. J. Lipid Res. 41, 521–531.

Corella D., Guillen M., Saiz C., Portoles O., Sabater A., Folch J., Ordovas J.M. Associations of LPL and APOC3 gene polymorphisms on plasma lipids in a Mediterranean population: Interaction with tobacco smoking and the APOE locus. J. Lipid Res. 2002;43:416–427.

Daoud, M. S., Ataya F.S., Fouad D., Alhazzani A., Shehata A.I., Al-Jafari A.A. et al. (2013) Associations of three lipoprotein lipase gene polymorphisms, lipid profiles and coronary artery disease. Biomed. Rep. 1, 573–582

Ehrhardt, N., Bedoya C, and Péterfy M, Embryonic viability, lipase deficiency, hypertriglyceridemia and neonatal lethality in a novel LMF1-deficient mouse model. Nutrition & metabolism, 2014. 11(1): p. 37.

Ferencak, G., Pasalić D., Grsković B., Cheng S., Fijal B., Sesto M. et al. (2003) Lipoprotein lipase gene polymorphisms in croatian patients with coronary artery disease. Clin. Chem. Lab. Med. 41, 541–546.

Goldberg, I. J. (2019) Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J. Lipid Res. 37, 693–707.

Gunn, K. H, Roberts BS, Wang F, Strauss JD, Borgnia MJ, Egelman EH, et al. The structure of helical lipoprotein lipase reveals an unexpected twist in lipase storage. Proc Natl Acad Sci U S A. (2020) 117(19):10254–64.

Gunn. K. H, et al., The structure of helical lipoprotein lipase reveals an unexpected twist in lipase storage. Proceedings of the National Academy of Sciences, 2020. 117(19): p. 10254–10264.

Handley, S. A, Wanandy T, Prentice L. Validation of the Randox colorimetric assays for serum copper and zinc. Ann Clin Biochem. 2024 May;61(3):182-194.. Humphries S.E., Nicaud V., Margalef J., Tiret L., Talmud P.J. Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: The European Atherosclerosis Research Study (EARS) Arterioscler. Thromb. Vasc. Biol. 1998;18:526–534].

Hwang J. & Qi L, Quality Control in the Endoplasmic Reticulum: Crosstalk between ERAD and UPR pathways. Trends in biochemical sciences, 2018. 43(8): p. 593–605.

Izar, M. C., Helfenstein T., Ihara S.S., Relvas W.G., Santos A.O., Fischer S.C. et al. (2009) Association of lipoprotein lipase D9N polymorphism with myocardial infarction in type 2 diabetes: the genetics, outcomes, and lipids in type 2 diabetes (GOLD) study. Atherosclerosis 204, 165–170

Jensen, M. K., Rimm E.B., Rader D., Schmidt E.B., Sorensen T.I., Vogel U., Overvad K., Mukamal K.J. S447X variant of the lipoprotein lipase gene, lipids, and risk of coronary heart disease in 3 prospective cohort studies. Am. Heart J. 2009;157:384–390.

Khongwichit, S., Swangphon P, Nanakorn N, Nualla-Ong A, Choowongkomon K, Lieberzeit PA, Chunta S. A simple aptamer/gold nanoparticle aggregation-based colorimetric assay for oxidized low-density lipoprotein determination. Talanta. 2023 Mar 1;254:124199.

Kim, M. S, Wang Y, Rodrigues B. Lipoprotein lipase mediated fatty acid delivery and its impact in diabetic cardiomyopathy. Biochim Biophys Acta (BBA) - Mol Cell Biol Lipids (2012) 1821(5):800–811.

Kim, G. H, et al. (2018). Hypothalamic ER–associated degradation regulates POMC maturation, feeding, and age-associated obesity. The Journal of clinical investigation, 2018. 128(3). Kumari A, Kristensen KK, Ploug M, Winther AL. The importance of lipoprotein lipase regulation in atherosclerosis. Biomedicines (2021) 9(7):782.

Li Y., Hew .P., Zhang D.W., Zheng X.L., Cayabyab F.S., Yin W.D. et al. (2014) Lipoprotein lipase: from gene to atherosclerosis. Atherosclerosis 237, 597–608 .

Murthy, V. J. P. & Gagne C. (1996) Molecular pathobiology of the human lipoprotein lipase gene. Pharmacol. Ther. 70, 101–135.

Nicklas, B. J., Ferrell R.E., Rogus E.M., Berman D.M., Ryan A.S., Dennis K.E., Goldberg A.P. Lipoprotein lipase gene variation is associated with adipose tissue lipoprotein lipase activity, and lipoprotein lipid and glucose concentrations in overweight postmenopausal women. Hum. Genet. 2000;106:420–424.

Péterfy M, Lipase maturation factor 1: a lipase chaperone involved in lipid metabolism. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, 2012. 1821(5): p. 790–794.

Preiss-Landl K., Zimmermann R., Hämmerle G. and Zechner R. (2002) Lipoprotein lipase: the regulation of tissue specific expression and its role in lipid and energy metabolism. Curr. Opin. Lipidol. 13, 471–481.

Qi L, Tsai B, & Arvan P, New insights into the physiological role of endoplasmic reticulum-associated degradation. Trends in cell biology, 2017. 27(6): p. 430–440.

Roberts. B. S, et al., Lipase maturation factor 1 affects redox homeostasis in the endoplasmic reticulum. The EMBO journal, 2018. 37(19-21)

Rodrigues B, Cam MC, Jian K, Lim F, Sambandam N, Shepherd G. Differential effects of streptozotocin-induced diabetes on cardiac lipoprotein lipase activity. Diabetes (1997) 46(8):1346–53.

Sayad A., Noruzinia M., Zamani M., Harirchian M.H., Kazemnejad A. Lipoprotein Lipase HindIII Intronic Polymorphism in a Subset of Iranian Patients with Late-Onset Alzheimer’s Disease. Cell J. 2012;14:67–72.

Shi. G, et al., ER-associated degradation is required for vasopressin prohormone processing and systemic water homeostasis. The Journal of clinical investigation, 2017. 127(10): p. 3897–3912.

Socquard, E., Durlach A., Clavel C., Nazeyrollas P., Durlach V. Association of HindIII and PvuII genetic polymorphisms of lipoprotein lipase with lipid metabolism and macrovascular events in type 2 diabetic patients. Diabetes Metab. 2006;32:262–269.

Tanguturi. P. R., Pullareddy B., Rama Krishna B.S., Murthy D.K. Lipoprotein lipase gene HindIII polymorphism and risk of myocardial infarction in South Indian population. Indian Heart J. 2013;65:653–657.

Tanguturi. P. R., Pullareddy B., Rama Krishna B.S. and Murthy D.K. (2013) Lipoprotein lipase gene HindIII polymorphism and risk of myocardial infarction in South Indian population. Indian Heart J. 65, 653–657 .

Toth, P. P. (2016) Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease. Vasc. Health Risk Manag. 12, 171–183.

Tripathi R Agarwal S. and Ramesh V.(2011) Lipoprotein lipase (A1127G) gene polymorphism: a case–control association study. Biochem. Genet. 49, 587–

Ukkola O., Garenc C., Perusse L., Bergeron J., Despres J.P., Rao D.C., Bouchard C. Genetic variation at the lipoprotein lipase locus and plasma lipoprotein and insulin levels in the Quebec Family Study. Atherosclerosis. 2021;158:199–206.

Van Bockxmeer F.M., Liu Q., Mamotte C. and Taylor R. (2001) Lipoprotein lipase D9N, N291S and S447X polymorphisms: their influence on premature coronary heart disease and plasma lipids. Atherosclerosis 157, 123–129]

Voss C.V., Davies B.S., Tat S., Gin P., Fong L.G., Pelletier C., Mottler C.D., Bensadoun A., Beigneux A.P., Young S.G. Mutations in lipoprotein lipase that block binding to the endothelial cell transporter GPIHBP1. Proc. Natl. Acad. Sci. USA. 2011;108:7980–7984.

Wion K.L., Kirchgessner T.G., Lusis A.J., Schotz M.C., Lawn R.M. Human lipoprotein lipase complementary DNA sequence. Science. 1987;235:1638–1641.

Zhang Y., Xie W., Li L., Zhang M., Cheng H.P., Gong D. et al. (2016) MicroRNA-27 prevents atherosclerosis by suppressing lipoprotein lipase-induced lipid accumulation and inflammatory response in apolipoprotein E knockout mice. PLoS One 11, e0157085 10.1371/journal.pone.